A selective degeneration of cholinergic neurons mediated by NRADD in an Alzheimer's disease mouse model.
A selective degeneration of cholinergic neurons mediated by NRADD in an Alzheimer's disease mouse model.
复制标题
阿尔茨海默病小鼠模型中 NRADD 介导的胆碱能神经元选择性变性
DOI:
10.1016/j.cellin.2022.100060
复制
发表时间:
2022-12
期刊:
影响因子:
--
通讯作者:
Li, Xinyan
中科院分区:
文献类型:
--
作者:
Li, Lanfang;Zhang, Bing;Tang, Xiaomei;Yu, Quntao;He, Aodi;Lu, Youming;Li, Xinyan
Cholinergic neurons in the basal forebrain constitute a major source of cholinergic inputs to the forebrain, modulate diverse functions including sensory processing, memory and attention, and are vulnerable to Alzheimer's disease (AD). Recently, we classified cholinergic neurons into two distinct subpopulations; calbindin D28K-expressing (D28K+) versus D28K-lacking (D28K−) neurons. Yet, which of these two cholinergic subpopulations are selectively degenerated in AD and the molecular mechanisms underlying this selective degeneration remain unknown. Here, we reported a discovery that D28K+ neurons are selectively degenerated and this degeneration induces anxiety-like behaviors in the early stage of AD. Neuronal type specific deletion of NRADD effectively rescues D28K+ neuronal degeneration, whereas genetic introduction of exogenous NRADD causes D28K− neuronal loss. This gain- and loss-of-function study reveals a subtype specific degeneration of cholinergic neurons in the disease progression of AD and hence warrants a novel molecular target for AD therapy. D28K+ cholinergic neurons are selectively degenerated in the early stage of AD. Deletion of NRADD in D28K+ neurons protects against neurodegeneration. Expression of exogenous NRADD in D28K− neurons causes neurodegeneration.